Alto Neuroscience, Inc. (ANRO)

USD 3.64

(-3.96%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021
Total Assets 86.62 Million 50.85 Million 28.79 Million
Total Current Assets 85.39 Million 49.22 Million 27.68 Million
Cash And Short Term Investments 82.54 Million 48.34 Million 25.7 Million
Cash and Cash Equivalents 82.54 Million 48.34 Million 25.7 Million
Short Term Investments - - -
Net Receivables 8000.00 546 Thousand 1.74 Million
Inventory - - -
Other Current Assets 2.83 Million 330 Thousand 236 Thousand
Total Non-Current Assets 1.23 Million 1.63 Million 1.1 Million
Net PPE 1.1 Million 1.57 Million 1.06 Million
Good Will And Intangible Assets - - -
Good Will - - -
Intangible Assets - - -
Long-Term Investments - - -
Tax Assets - - -
Other Non Current Assets 130.99 Thousand 55 Thousand 49.99 Thousand
Other Assets 1.00 - 1.00
Total Liabilities 158.3 Million 89.26 Million 41.27 Million
Total Current Liabilities 5.61 Million 5.56 Million 1.81 Million
Account Payables 1.07 Million 1.6 Million 600 Thousand
Tax Payables - - -
Short Term Debt 125 Thousand 283 Thousand -
Deferred Revenue - - -
Other Current Liabilities 4.41 Million 3.67 Million 1.21 Million
Total Non Current Liabilities 152.69 Million 83.7 Million 39.46 Million
Long-Term Debt 151.33 Million 81.7 Million 38.16 Million
Deferred Revenue Non Current - - -
Deferred Tax Liabilities Non Current - - -
Other Non Current Liabilities 1.35 Million 2 Million 1.29 Million
Other Liabilities - - 1.00
Total Equity -71.67 Million -38.4 Million -12.47 Million
Stock Holders Equity -71.67 Million -38.4 Million -12.47 Million
Common Stock - 1000.00 1000.00
Retained Earnings -76.96 Million -40.66 Million -12.95 Million
Accumulated other comprehensive income -79 Thousand -46 Thousand -22 Thousand
Common Stock Equity -71.67 Million -38.4 Million -12.47 Million
Capital Lease Obligation 125 Thousand 123 Thousand -
Total Investments - - -
Total Debt 151.46 Million 82.1 Million 38.16 Million
Net Debt 68.91 Million 33.76 Million 12.45 Million

Balance Sheet Charts